Paul Hartman

478 citations
9 papers · 381 indexed · h-index 8
Topics
Angiogenesis and VEGF in Cancer (3 papers)Cancer Treatment and Pharmacology (3 papers)Acute Myeloid Leukemia Research (2 papers)

In The Last Decade

Paul Hartman

9 papers receiving 374 citations

Peers

Paul Hartman
Comparison fields: 5 of 60
  • Oncology 163
  • Molecular Biology 147
  • Cancer Research 99
  • Endocrinology, Diabetes and Metabolism 75
  • Organic Chemistry 69
Replace John Waas with:
John Waas United States
S. Kim United States
Shinji Oie Japan
Diana Bello United States
James Zweibel United States
Jason L. Rowand United States
F G Hay United Kingdom
Tadao Manabe Japan
Frank Schönsiegel Germany
Dongweon Song United States
Paul Hartman relative to John Waas United States John Waas's profile →
Citations per field
00.5×1.5×
John Waas · 1×
Citations per year

Countries citing papers authored by Paul Hartman

Since Specialization
Citations

This map shows the geographic impact of Paul Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hartman more than expected).

Fields of papers citing papers by Paul Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hartman. The network helps show where Paul Hartman may publish in the future.

Co-authorship network of co-authors of Paul Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hartman. A scholar is included among the top collaborators of Paul Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hartman. Paul Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 153
2 80
3 14
4 36
5 30
6
Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies.
38
7
A phase I pharmacokinetic and pharmacodynamic study of SU5416 and Adriamycin in inflammatory breast cancer
13
8 5
9 12

About Paul Hartman

Paul Hartman is a scholar working on Cancer Research, Genetics and Hematology, having authored 9 papers that have together received 381 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Cancer Treatment and Pharmacology (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Cancer Research (99 citations), Oncology (163 citations) and Endocrinology, Diabetes and Metabolism (75 citations). Paul Hartman has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Scot C. Remick, Afshin Dowlati, Jay Wasman, Pingfu Fu, Susan M. Flick, P. Savvides, Colin Mooney, Sanjiv S. Agarwala, Govardhanan Nagaiah and José Ortiz. Their work appears in journals such as Clinical Cancer Research, Tetrahedron Letters and The American Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026